جستجوی استاد راهنمای دانشگاهی

Sriram Subramaniamمشاهده پروفایل

استاد

• cryo-electron microscopy
• structural biology
• drug-design
• +۴ مورد دیگر

Sriram Subramaniam is a Professor in the Department of Biochemistry and Molecular Biology at the University of British Columbia (UBC) and holds the Gobind Khorana Canada Excellence Research Chair in Precision Cancer Drug Design. His research leverages cryo-electron microscopy (cryo-EM) to advance structural biology and drug design, focusing on protein dynamics and therapeutic target identification. Education: PhD in Physical Chemistry (1987) from Stanford University; MSc in Chemistry (1981) from Indian Institute of Technology, Kanpur. Subramaniam's interdisciplinary work combines cryo-EM with computational tools and molecular biology to study protein structures at atomic resolution. His lab has pioneered cryo-EM applications in precision medicine, including mapping small molecule drugs on patient-specific cancer mutants. Recent publications (2024-2022) highlight his contributions to understanding SARS-CoV-2 immune evasion, structural mechanisms of ATPases, and AI integration in structural biology. His research spans viral entry mechanisms, CRISPR systems, and neurodegenerative disease pathways. Scientific Awards: Gobind Khorana Canada Excellence Research Chair NIH Director’s Award for Scientific Excellence Fellow of the Biophysical Society Breakthrough Prize nomination Based at the Djavad Mowafaghian Center for Brain Health, Subramaniam leads the Program in Cryo-EM Guided Drug Design, contributing to over 177 peer-reviewed publications with a career h-index of 58 and citations exceeding 12,340.

• Drug Delivery
• Nanomedicine
• Biopharmaceutics
• +۷ مورد دیگر

Dr. Shyh-Dar Li is a Professor and Tong Louie Chair in Pharmaceutical Sciences at the University of British Columbia's Faculty of Pharmaceutical Sciences, where he also serves as Chair of Nanomedicine and Chemical Biology. With a BSc in pharmacy from National Taiwan University (1998) and PhD in pharmaceutical sciences from UNC Chapel Hill (2008), followed by postdoctoral training at UC San Diego's Moores Cancer Center (2009), Dr. Li has established himself as a leading researcher in advanced drug delivery systems. His research focuses on developing innovative nanomedicine platforms for targeted delivery of biological therapeutics including peptides, proteins, antibodies, and nucleic acids. Dr. Li's laboratory has pioneered several novel drug delivery approaches, particularly in lipid-based nanoparticles, phospholipid-free vesicles, and polymer systems for cancer immunotherapy, pain management, and protein delivery. His work bridges fundamental nanotechnology with translational applications for difficult-to-treat diseases. Analysis of his recent publications reveals a strong emphasis on tumor microenvironment modulation, endosomal escape mechanisms for nucleic acid delivery, and non-invasive delivery routes for protein therapeutics. His research demonstrates increasing sophistication in nanocarrier engineering, with recent work incorporating machine learning approaches to optimize nanoparticle design and expanding into immunomodulatory therapies that harness the body's immune system to fight cancer. Scientific Recognition: 2014 AFPC New Investigator Award 2013 AAPS New Investigator Award in Pharmaceutics and Pharmaceutical Technologies 2013 CIHR New Investigator Award 2013 CSPS Early Career Award 2012 Prostate Cancer Foundation Young Investigator Award Dr. Li's research program has been consistently supported by major Canadian funding agencies including CIHR, NSERC, and MITACS. He actively collaborates across disciplines and accepts graduate students into his research program, focusing on cutting-edge approaches to overcome biological barriers in drug delivery. His laboratory, the Laboratory of Targeted Drug Delivery and Nanomedicine, serves as a hub for innovation in pharmaceutical nanotechnology.

Vikramaditya G. Yadavمشاهده پروفایل

دانشیار

• Biocatalysis
• Bioremediation
• Bioprocess engineering
• +۱۵ مورد دیگر

Vikramaditya G. Yadav is an Associate Professor at the University of British Columbia (UBC) in the Department of Chemical and Biological Engineering, Faculty of Applied Science. He directs the Master of Engineering Leadership (MEL) Program in Sustainable Process Engineering and leads the BioFoundry research group. Education: B.A.Sc., University of Waterloo (2007) Ph.D., Massachusetts Institute of Technology (2013) Postdoctoral Associate, Harvard University (2014) His research spans sustainable chemical manufacturing, metabolic engineering, and biotechnology. Key areas include: Designing biosynthetic enzymes for biomass valorization Developing bioremediation strategies for industrial water quality Creating innovative drug delivery systems and tissue engineering solutions Advancing synthetic biology for pharmaceutical and bioenergy applications His recent work focuses on ocular drug delivery, cannabinoid biosynthesis in E. coli, lignin-based nanoparticles for cancer therapy, and computational analysis of plant secondary metabolites. Collaborations with start-ups, industry, and medical labs drive innovation in Canada's bioeconomy. Professional Leadership: Chair, Biotechnology Division of the Chemical Institute of Canada Associate Editor, The Canadian Journal of Chemical Engineering He is affiliated with UBC's BioProducts Institute and contributes to project-based learning pedagogy.

• Behavioral Economics
• Intertemporal Choice
• Risky Choice
• +۲ مورد دیگر

Charles D. Sprenger is a Professor of Economics at the California Institute of Technology (Caltech), where he has served since 2020 and held the position of Executive Officer from 2022 to 2025. He is affiliated with Caltech's Division of the Humanities and Social Sciences (HSS) and holds key roles at the Ronald and Maxine Linde Institute of Economic and Management Sciences and the Center for Theoretical and Experimental Social Sciences (CTESS). His external appointments include Board of Editors for the American Economic Review and Associate Editor roles for the Journal of the European Economic Association and Quantitative Economics . His educational background includes a B.A. from Stanford University (2002), an M.Sc. from University College London (2005), and a Ph.D. from the University of California, San Diego (2011). These credentials established his foundation in economic theory and experimental methodology. Sprenger is a leading behavioral and experimental economist specializing in intertemporal decision making and choices under uncertainty. His research designs innovative experiments across diverse contexts—from food deserts in the United States to polio vaccination drives in Pakistan—to test the validity of standard economic models. His work consistently reveals significant deviations from rational choice theory, particularly regarding time inconsistency, risk preferences, and reference-dependent behaviors. He has pioneered methods for measuring time preferences and testing cumulative prospect theory, with implications for public policy and behavioral interventions. Analysis of his 15 most recent publications (2015-2024) shows a cohesive research program centered on behavioral anomalies in decision making. His work bridges laboratory precision with real-world field applications, demonstrating how psychological factors like procrastination and loss aversion manifest in high-stakes environments. Key trends include the development of tailored incentive structures, validation of rank-dependent utility models, and exploration of dynamic inconsistency across domains including health, finance, and public policy. His notable recognition includes: Sloan Foundation Fellowship (2016-2018) Sprenger actively contributes to the academic community through editorial leadership and collaborative research. His work has been featured in Caltech news for projects like "Reducing Procrastination with Tailored Incentives" (2023) and the graduate summer program "Experimental Economics in Theory and Practice" (2023). Though specific advisees aren't listed, his teaching of advanced courses like Experimental Economics (SS 212 abc) indicates mentorship of graduate researchers. He secures significant research funding through fellowships and institutional support, enabling large-scale field experiments. As a core member of CTESS, Sprenger leads a multidisciplinary team conducting cutting-edge experimental economics research. His lab integrates theoretical modeling with empirical validation, focusing on how behavioral insights can improve policy design in areas like tax compliance, vaccination programs, and financial decision making. Current work emphasizes scalable interventions for procrastination and preference-based incentive customization.

Burak Ozdoganlarمشاهده پروفایل

استاد

• Manufacturing Processes
• Biomedical Engineering
• Materials Science
• +۷ مورد دیگر

Burak Ozdoganlar is a Ver Planck Endowed Chair Professor of Mechanical Engineering at Carnegie Mellon University (CMU) and Associate Director of the Engineering Research Accelerator. He holds courtesy faculty positions in Biomedical Engineering and Materials Science and Engineering. Ozdoganlar earned his Ph.D. in Mechanical Engineering from the University of Michigan (1999), M.S. degrees from Ohio State University (1993, 1995), and a B.S. in Aeronautical Engineering from Istanbul Technical University (1991). Ph.D., Mechanical Engineering, University of Michigan (1999) MS, Mechanical Engineering, Ohio State University (1995) MS, Aeronautical and Astronautical Engineering, Ohio State University (1993) BS, Aeronautical Engineering, Istanbul Technical University (1991) Ozdoganlar’s research focuses on multi-scale manufacturing processes (macro/micro/nano), precision engineering , structural dynamics , and modal testing , with applications in biomedical device fabrication , microneedle arrays , soft electronics , and 3D ice printing for vascular networks. His work bridges computational modeling with experimental validation. Recent scientific awards include the 2023 AIMBE College of Fellows induction, ASME Fellow (2019), and NSF CAREER Award (2006). He served as interim CTO of the Advanced Robotics for Manufacturing (ARM) Institute and chaired the ASME-MED Manufacturing Equipment Technical Committee. Ozdoganlar leads projects in scalable manufacturing for implantable medical devices , bioelectric medicine , and wearable robotics . His lab develops 3D ice-printed vascular templates for tissue engineering and liquid metal circuits for soft electronics, funded by institutions like the Manufacturing Futures Institute and ARPA-H.

Kelly Arnoldمشاهده پروفایل

دانشیار

• Biomedical Computation and Modeling
• Drug Delivery and Therapeutics
• Systems Immunology
• +۵ مورد دیگر

Kelly Arnold is an Associate Professor in the Department of Biomedical Engineering at the University of Michigan. Her research integrates systems engineering principles with immunology to investigate variability in immune responses across infection, vaccination, and injury, with a focus on computational modeling and clinical translation. Research Focus Systems-level immune response modeling Vaccination and antibody functionality Vaginal microbiome-host interactions Chronic lung disease progression Computational serology and proteomics Recent Work Her 2025 studies examine SARS-CoV-2 vaccination responses in cancer patients and computational frameworks for vaginal probiotics. Earlier works (2024-2007) span COPD progression, lupus fibrosis, HIV susceptibility, and tissue engineering for fertility preservation. Methodologies include proteomic profiling, network modeling, and microfluidic systems.

Konstantin (Kostia) M. Zuevمشاهده پروفایل

استاد آموزشی

• Network Science
• Applied Probability
• Computational Statistics
• +۴ مورد دیگر

Dr. Konstantin (Kostia) M. Zuev serves as Teaching Professor in the Computing + Mathematical Sciences Department at California Institute of Technology , where he has made significant contributions to network science and computational statistics since 2016. His dual PhDs in Mathematics (Moscow State University, 2008) and Civil Engineering (HKUST, 2009) underpin his interdisciplinary research spanning differential geometry, stochastic simulation, and network dynamics. Education PhD in Mathematics, Lomonosov Moscow State University (2008) PhD in Civil Engineering, Hong Kong University of Science & Technology (2009) His research focuses on network science , particularly course-prerequisite networks and complex financial systems , with recent work extending to network navigability in cosmological models and rare event simulation. Over his career, he has developed innovative Bayesian inference methods and geometric preferential attachment theories while maintaining active collaborations across mathematics, physics, and biomedical domains. Recent publications highlight network analysis in education ( 2023 ), hyperbolic graph theory ( 2024 ), and pandemic-informed cancer mortality studies ( 2023 ). His 15 most recent articles demonstrate methodological innovations across disciplines including statistics, physics, finance, and cosmology. Scientific recognition includes Humboldt Research Fellowship (2021) Carver Mead Seed Fund Grant (2023) ASCIT Teaching Award (2018, 2023) Northrop Grumman Teaching Excellence Prize (2019) As Graduate Option Representative for Information and Data Sciences at Caltech and faculty advisor for multiple student organizations including the Caltech Karate Club and Caltech Chess Club , he actively bridges academic rigor with community engagement through outreach initiatives like the virtual math education channel and university math circles for K-12 students.

Ashli Owen-Smithمشاهده پروفایل

پژوهشگر

• Mental Health
• Behavioral Science
• Trauma
• +۶ مورد دیگر

Ashli Owen-Smith is a behavioral scientist affiliated with the School of Public Health at Georgia State University , where her research focuses on mental health disparities, suicide prevention, and integrative/complementary approaches for complex mental-physical health conditions. She works with underserved populations including refugees/immigrants, incarcerated individuals, and LGBTQ+ communities through community-based participatory research and mixed-methods frameworks. Her current projects are funded by CDC , DBHDD , and DPH . Education: Ph.D. in Behavioral Sciences (Emory, 2009), S.M. in Public Health (Harvard, 2005), B.A. in Psychology (Smith College, 2001) Her research spans mental health , trauma , suicide prevention , and mindfulness-based interventions . Recent work examines telehealth adaptations for chronic pain and mental health, vaccine hesitancy in refugee communities, and social determinants of suicide . She leads studies on gender-affirming care and health disparities in LGBTQ+ populations. Key article trends include epidemiological analysis of suicide risk factors, COVID-19 impacts on mental health, ICD-10 coding for autism, and complementary medicine in trauma recovery. Subfields span telehealth , health equity , mental-physical comorbidity , and community engagement . Students she has mentored include C.A. Scarlett , T. Griner , and M.M. Sesay . Her work integrates public health policy , clinical research , and health systems analysis .

Sachdev Sidhuمشاهده پروفایل

استاد پژوهش

• Synthetic Antibodies
• Protein Engineering
• Biotechnology
• +۵ مورد دیگر

Sachdev Sidhu is a Research Professor and Entrepreneur in Residence at the University of Waterloo. His research focuses on synthetic antibodies, protein engineering, and biotechnological applications. He leads efforts in developing novel therapeutic antibodies, engineered protein systems, and molecular tools for biomedical research. His work spans cancer therapy, viral infection countermeasures, and regenerative medicine. Sidhu is also involved in translational research, bridging academic discoveries with commercial applications through entrepreneurial ventures. Key research interests include synthetic antibody libraries, CAR T-cell engineering, ubiquitin-based therapeutics, and phage display technologies. He has contributed to advancements in targeted therapies for glioblastoma, leukemia, and ocular diseases. His team develops innovative methods for protein design, such as engineered ubiquitin variants and modular antibody architectures. Publications highlight breakthroughs in antibody-based treatments, including synNotch CAR T cells for glioblastoma and neutralizing antibodies against SARS-CoV-2. His work integrates structural biology, molecular biology, and computational approaches to address complex biomedical challenges. Sidhu collaborates with industry partners to advance technologies into clinical and commercial settings.

Tracey Gallowayمشاهده پروفایل

دانشیار

• Indigenous health
• circumpolar populations
• nutrition transition
• +۷ مورد دیگر

Tracey Galloway is an Associate Professor in the Department of Anthropology at the University of Toronto Mississauga (UTM), where she conducts critical research on Indigenous health disparities and policy interventions in northern Canada. Her work bridges medical anthropology, public health, and community-based participatory research to address systemic inequities affecting circumpolar populations. Education: PhD, McMaster University, 2008 MA (institution unspecified) BA (institution unspecified) BScN (institution unspecified) Dr. Galloway's research program centers on chronic disease risk assessment and health system improvement in Indigenous communities, with specific expertise in nutrition transition, food security, child growth patterns, and public health policy evaluation. She examines the impact of federal programs like Nutrition North Canada while developing community-led solutions for health equity. Her methodological approach combines quantitative analysis of health outcomes with qualitative community engagement, emphasizing Indigenous research sovereignty and decolonizing methodologies. Her publication record reveals consistent thematic focus across 15 recent articles, demonstrating interdisciplinary collaboration between anthropology, epidemiology, and health economics. Key trends include rigorous evaluation of colonial impacts on Indigenous food systems, innovative analysis of subsidy program effectiveness, and centering Indigenous patient experiences in healthcare design. Her work consistently prioritizes community-defined research questions and actionable policy recommendations. Dr. Galloway actively mentors graduate students including Darci Belmore, Carly Checholik, Neda Maki, and Hiliary Monteith, guiding research on Indigenous health determinants and policy interventions. While specific grant details aren't publicly enumerated, her collaborative projects involve partnerships with Indigenous communities across Northern Canada and interdisciplinary teams addressing complex health system challenges. She maintains strong community partnerships for her applied research, particularly in Nunavut and Northwestern Ontario, working directly with Anishinabeck and Inuit communities to translate findings into culturally safe health initiatives and policy reforms that address the root causes of health inequities.

• Nuclear Magnetic Resonance (NMR)
• In vivo imaging
• MRI pulse sequence development
• +۷ مورد دیگر

Professor Guy Williams is a leading academic at the University of Cambridge with a focus on imaging science and clinical neurosciences, affiliated with Downing College and the Wolfson Brain Imaging Centre . Holding a PhD in Physics from his initial Natural Sciences degree, he specializes in nuclear magnetic resonance (NMR) and MRI techniques for brain imaging. Education: BA, PhD in Physics His research centers on non-invasive imaging of brain structure and function, particularly in traumatic brain injury (TBI) and dementia. His work involves developing novel MRI pulse sequences and advanced data analysis algorithms, including AI-based diagnostic tools. He leads studies on white matter integrity post-trauma, longitudinal dementia assessment, and applications of MRI in disorders of consciousness and addiction. Recent publications highlight collaborations in traumatic brain injury outcomes, AI-guided dementia prediction, and neuroimaging of post-COVID cognitive deficits. His team's work on ultra-high field laminar fMRI and distortion correction methods has advanced clinical neuroscience applications. Key techniques include diffusion tensor imaging (DTI), 7 Tesla MRI, and positron emission tomography (PET/MR). His research spans from basic NMR physics to clinical translation, with a strong emphasis on multi-site studies and real-world diagnostic implementation.

• Medical Statistics
• Biostatistics
• Epidemiology
• +۳ مورد دیگر

Ruth Keogh is a Professor of Biostatistics and Epidemiology at the London School of Hygiene & Tropical Medicine (LSHTM), affiliated with the Medical Statistics Department within the Faculty of Epidemiology and Population Health. She is Co-Director of the Centre for Data and Statistical Science for Health (DASH) and serves as Departmental Research Degrees Coordinator. Her academic career has spanned roles from Lecturer (2012–2015) to Associate Professor (2015–2019) before attaining her current rank in 2019. Keogh holds advanced degrees including a DPhil in Medical Statistics/Epidemiology (University of Oxford, 2007), MSc in Applied Statistics (Oxford, 2003), and BSc in Mathematics and Statistics (University of Edinburgh, 2002). Her research focuses on causal inference, clinical trial emulation using real-world data, and applications in cystic fibrosis, infectious diseases, and public health. She leads projects on lung function trajectories, vaccine efficacy, and healthcare policy analysis. Her work integrates biostatistical methods with epidemiological studies, emphasizing rigorous analysis of observational data to inform clinical decisions. Notable areas include evaluating antibiotic treatments for cystic fibrosis patients, assessing diagnostic test accuracy for dengue and leptospirosis, and modeling vaccine effectiveness during the COVID-19 pandemic. She teaches courses in survival analysis, electronic health records, and health data science at LSHTM. Keogh has held leadership roles in the International Biometric Society and the STRATOS Initiative, and she has delivered keynote addresses at international conferences on trial emulation and biostatistical methods. Her contributions bridge methodological innovation and practical health challenges, with over 190 publications and active engagement in global health research networks.

Paula Gonzalez-Figueroaمشاهده پروفایل

پژوهشگر ارشد

• Immunology
• Autoimmunity
• Allergy
• +۶ مورد دیگر

Dr. Paula Gonzalez-Figueroa is a Research Fellow at the Clinical Hub for Interventional Research (CHOIR) in the College of Health and Medicine at The Australian National University (ANU). She holds a PhD in Medical Sciences from ANU and completed postdoctoral research at the John Curtin School of Medical Research (ANU) and the Francis Crick Institute (UK). Her research focuses on immunology, autoimmunity, allergy, and clinical translation. Education: PhD in Medical Sciences (ANU), Biotechnology degree. Research Interests: Regulatory T cells, germinal centers, B cell biology, neuritin-based therapies, preclinical drug testing, and early-phase clinical trials. Affiliations: CHOIR (Researcher), Polizzotto Group, Genome Sciences and Cancer Division. Her work includes developing a neuritin-based biotherapeutic for allergies and autoimmune diseases, and leading preclinical/Phase I clinical programs for hematological cancers. She has contributed to studies on Tfr cell regulation, IgE responses, and germinal center dynamics. Publications span immunology, molecular biology, and translational research, with notable contributions to Nature Immunology , Cell , and Journal of Experimental Medicine .

Matthias Barzمشاهده پروفایل

استاد

• Polymer Science
• Biotherapeutic Delivery
• Nanoparticle Synthesis
• +۷ مورد دیگر

Matthias Barz is a Professor of Biotherapeutic Delivery at the Leiden Academic Centre for Drug Research (LACDR) , Faculty of Science , Leiden University . He leads the Barz Lab , focusing on polymer science and biomedical applications of functional nanoparticles. Professor of Biotherapeutic Delivery (Leiden University) Head of the Division of BioTherapeutics Researcher in reactive polymer systems and nanocarrier design His research bridges polymer chemistry with biomedical applications, emphasizing polypept(o)ide-based nanocarriers for targeted drug delivery in cancer, inflammation, and neurodegenerative diseases. Key areas include: Stimuli-responsive polymer architectures Secondary structure-driven self-assembly Core-crosslinked micelles for controlled cargo release Redox-sensitive disulfide bonds for intracellular delivery Protein-repellent nanoparticle shells Riboflavin-functionalized nanocarriers for tumor targeting The lab's publications highlight advancements in polysarcosine-containing copolymers , orthogonal functional group utilization , and modular nanoparticle platforms with precise control over morphology and function. Current projects explore the clinical translation of these systems for immunotherapy and diagnostics. Scientific recognition includes: Dozentenpreis des Fonds der Chemischen Industrie (2018) PMSE Young Investigator Award (2018) Nachwuchswissenschaftlerstipendium der GDCh (2017) His team trains graduate students in polymer synthesis, nanoparticle characterization, and biomedical application testing. Collaborations span institutions like the University of Tokyo and Johannes Gutenberg University Mainz , with ongoing projects under the SFB 1066 initiative for malignant melanoma immunotherapy.

Ali Gilles Tchenguise Miserezمشاهده پروفایل

استاد

• Biological Materials
• Biomimetics
• Bioinspired Materials
• +۷ مورد دیگر

Professor Ali Gilles Tchenguise Miserez holds a joint appointment as Professor in the School of Materials Science and Engineering and the School of Biological Sciences at Nanyang Technological University (NTU) in Singapore. He is also the President's Chair in Materials Science and Engineering. His research group, the Biological and Biomimetic Materials Laboratory (BBML), is highly interdisciplinary, bringing together molecular biologists, chemists, bio-physicists, and materials scientists to study natural materials with unique properties not found in man-made materials. Prof. Miserez's research interests span multiple areas including bioelastomeric membranes & coiled-coil engineering, mechanisms of biofouling adhesion & anti-adhesive coatings, molecular biomimetics of non-mineralized hard tissues, biomineralized structures with graded properties, and liquid-liquid phase separation. His work focuses on understanding the molecular, physico-chemical, and structural principles of biological materials and translating these designs into novel biomimetic synthesis strategies. His laboratory emphasizes "green chemistry" approaches that mimic nature's energy-efficient synthesis methods under ambient conditions. Prof. Miserez's publication record demonstrates significant impact across multiple disciplines, with work appearing in top journals including Science, Nature Materials, Nature Biotechnology, Nature Chemical Biology, and Advanced Materials. His recent research has particularly focused on peptide coacervates for intracellular delivery of therapeutics, with applications in cancer treatment, mRNA delivery, and nucleic acid therapeutics. This work represents a convergence of materials science, biochemistry, and medicine with significant translational potential. Singapore National Research Foundation (NRF) Fellowship (2011) - $3 Million individual research grant for early career scientists Prof. Miserez has mentored numerous PhD students and postdoctoral researchers, many of whom have gone on to successful careers in academia and industry. His laboratory has developed strong international collaborations and has secured significant research funding. Current projects include developing peptide-based delivery systems for cancer therapeutics, understanding marine biofouling mechanisms, and creating biomimetic materials inspired by natural systems. The BBML laboratory is actively recruiting talented researchers interested in interdisciplinary work at the interface of biology and materials science.